Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：1.4 Date：2024-08-30

Revista Brasileira de Farmacognosia

Icariside II Suppresses the Malignant Behaviors of Breast Cancer Cells by Inhibiting PTGES3 Expression

Products： EA015、 EP013、 EQ001
IF：1.4 Date：2025-02-18

Tissue and Cell

Granisetron ameliorates doxorubicin-evoked nephrotoxicity via modulation of Nrf2 and TLR4/p38 MAPK/NLRP3 signals in rats

Products： ELK1396
IF：1.4 Date：2025-02-18

Jove-Journal of Visualized Experiments

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Products：
IF：1.4 Date：2025-03-17

Turkish Journal of Gastroenterology

Metabolic and Hepatic Profiles of Non-Obese and Obese Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents: The Role of FibroScan Parameters,Fibroblast Growth Factor-21, and Cytokeratin-18

Products： ELK1323、 ELK8576

< Page of 454 >